BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26186252)

  • 1. C5b-9 Staining Correlates With Clinical and Tumor Stage in Gastric Adenocarcinoma.
    Chen J; Yang WJ; Sun HJ; Yang X; Wu YZ
    Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):470-5. PubMed ID: 26186252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
    Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
    World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis.
    Sun A; Yu G; Dou X; Yan X; Yang W; Lin Q
    Mol Cancer; 2014 Nov; 13():248. PubMed ID: 25395181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
    Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
    World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Annexin A1 protein expression in human gastric adenocarcinoma using proteomics and tissue microarray.
    Zhang ZQ; Li XJ; Liu GT; Xia Y; Zhang XY; Wen H
    World J Gastroenterol; 2013 Nov; 19(43):7795-803. PubMed ID: 24282368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C5b-9 Membrane Attack Complex Formation and Extracellular Vesicle Shedding in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Kolka CM; Webster J; Lepletier A; Winterford C; Brown I; Richards RS; Zelek WM; Cao Y; Khamis R; Shanmugasundaram KB; Wuethrich A; Trau M; Brosda S; Barbour A; Shah AK; Eslick GD; Clemons NJ; Morgan BP; Hill MM
    Front Immunol; 2022; 13():842023. PubMed ID: 35345676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of maspin expression in human gastric adenocarcinoma.
    Song SY; Son HJ; Kim MH; Nam ES; Rhee JC; Park C
    Hepatogastroenterology; 2007; 54(75):973-6. PubMed ID: 17591106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of cytoplasmic transducer of ErbB2. 1 expression in gastric cancer.
    Zhang SQ; Sun KK; Wu XY; Zhong N; Zhao H; Li DC
    Mol Med Rep; 2015 Jul; 12(1):1177-82. PubMed ID: 25760308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
    Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
    World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C4d staining as immunohistochemical marker in inflammatory myopathies.
    Pytel P
    Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):696-704. PubMed ID: 24897075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrotic mechanisms in idiopathic rapidly progressive glomerulonephritis: the role of TGF-beta1 and C5b-9.
    Gionanlis L; Alexopoulos E; Papagianni A; Leontsini M; Memmos D
    Ren Fail; 2008; 30(2):239-46. PubMed ID: 18300128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma.
    Wang D; Wang L; Zhou J; Pan J; Qian W; Fu J; Zhang G; Zhu Y; Liu C; Wang C; Jin Z; He Z; Wu J; Shi B
    PLoS One; 2014; 9(11):e113754. PubMed ID: 25412184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of complement regulating factors in gastric cancer cells.
    Inoue T; Yamakawa M; Takahashi T
    Mol Pathol; 2002 Jun; 55(3):193-9. PubMed ID: 12032231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma.
    Ben Ayed-Guerfali D; Charfi S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
    Cancer Biomark; 2016 Jun; 17(1):67-73. PubMed ID: 27314294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression profiling of gastric intraepithelial neoplasia and early-stage adenocarcinoma.
    Xu X; Feng L; Liu Y; Zhou WX; Ma YC; Fei GJ; An N; Li Y; Wu X; Yao F; Cheng SJ; Lu XH
    World J Gastroenterol; 2014 Dec; 20(47):17883-93. PubMed ID: 25548486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma.
    Ohno S; Tachibana M; Fujii T; Ueda S; Kubota H; Nagasue N
    Int J Cancer; 2002 Feb; 97(6):770-4. PubMed ID: 11857352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric adenocarcinoma: a comparison of the accuracy and economics of staging by computed tomography and surgery.
    Moss AA; Schnyder P; Marks W; Margulis AR
    Gastroenterology; 1981 Jan; 80(1):45-50. PubMed ID: 6778759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention.
    Fishelson Z; Kirschfink M
    Front Immunol; 2019; 10():752. PubMed ID: 31024572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
    Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.